Who
Jessica Newcomb
Principal Accounting Officer
Company insider
Files Form 4 as: Principal Accounting Officer, Tango Therapeutics.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $397K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Sep 2026
- Last trade
- 22 Sep 2026
- Last filed
- 24 Sep 2026
Companies traded
Activity over time
1 Sep – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Sep 2026filed 24 Sep 2026 | TNGX Tango TherapeuticsBiotechnology | SEC FORM 4 Sold | $16K700 at $22.80 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TNGX Tango TherapeuticsBiotechnology | SEC FORM 4 Sold | $122K5,100 at $23.97 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TNGX Tango TherapeuticsBiotechnology | SEC FORM 4 Sold | $60K2,400 at $25.17 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TNGX Tango TherapeuticsBiotechnology | SEC FORM 4 Sold | $16K700 at $22.80 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TNGX Tango TherapeuticsBiotechnology | SEC FORM 4 Sold | $122K5,100 at $23.97 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TNGX Tango TherapeuticsBiotechnology | SEC FORM 4 Sold | $60K2,400 at $25.17 | filing |
News
Tango Therapeutics (TNGX) Has Striking Pancreatic Cancer Data. How Much Is Priced In?TNGX · insidermonkey.com · 20 Oct 2026Tango Therapeutics (NASDAQ:TNGX) Shares Up 7.5% – Should You Buy?TNGX · dailypolitical.com · 19 Oct 2026
0 headlines in the last 90 days name Jessica Newcomb; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.